RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference35 articles.
1. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma;Van Meir;CA Cancer J. Clin.,2010
2. Self-reported cognitive impairment in patients with cancer;Kohli;J. Oncol. Pract.,2007
3. Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014;Ostrom;JAMA Oncol.,2018
4. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data;Zhang;J. Cell Biochem.,2019
5. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol.,2007
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. WSCD2 Expression: Its Relevance to Tumor-Infiltrating Immune Cells and Glioma Prognosis;Current Medicinal Chemistry;2024-02-26
2. The RELT Family of Proteins: An Increasing Awareness of Their Importance for Cancer, the Immune System, and Development;Biomedicines;2023-10-02
3. Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma;Stem Cells International;2023-04-30
4. Diversity and heterogeneity in human breast cancer adipose tissue revealed at single-nucleus resolution;Frontiers in Immunology;2023-04-21
5. Prognostic significance of TMEM131L in glioma and establishment of oxidative stress prognostic model;Frontiers in Neurology;2023-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3